Showing 1 to 10 of 10 results
£800,000 boost for Northern Ireland gender identity services sparks debate
Northern Ireland's Health Minister Mike Nesbitt defended an £800,000 funding increase for gender identity services, aiming to address long waiting lists (1,163 adults, 45 children) and ensure compliance with a UK puberty blocker ban, despite criticism from unionist parties citing the health service ...
£800,000 boost for Northern Ireland gender identity services sparks debate
Northern Ireland's Health Minister Mike Nesbitt defended an £800,000 funding increase for gender identity services, aiming to address long waiting lists (1,163 adults, 45 children) and ensure compliance with a UK puberty blocker ban, despite criticism from unionist parties citing the health service ...
Progress
60% Bias Score
Australia to Review Gender-Affirming Care for Transgender Youth
Australia's federal government launched a review of gender-affirming care for transgender children and adolescents, prompted by Queensland's decision to pause such treatments, aiming to create national guidelines based on evidence and best practices by mid-2024.
Australia to Review Gender-Affirming Care for Transgender Youth
Australia's federal government launched a review of gender-affirming care for transgender children and adolescents, prompted by Queensland's decision to pause such treatments, aiming to create national guidelines based on evidence and best practices by mid-2024.
Progress
52% Bias Score
Study: Gender-Affirming Care for Transgender Youth in US Far Less Common Than Perceived
A new analysis of nearly 5.2 million US adolescents (2018-2022) shows that prescriptions of puberty blockers and gender-affirming hormones for transgender youth are rare; only 20.81 per 100,000 biologically female teens received puberty blockers, and 49.9 per 100,000 received hormones, challenging p...
Study: Gender-Affirming Care for Transgender Youth in US Far Less Common Than Perceived
A new analysis of nearly 5.2 million US adolescents (2018-2022) shows that prescriptions of puberty blockers and gender-affirming hormones for transgender youth are rare; only 20.81 per 100,000 biologically female teens received puberty blockers, and 49.9 per 100,000 received hormones, challenging p...
Progress
40% Bias Score
U.K. Indefinitely Bans New Puberty Blocker Prescriptions for Transgender Minors
The U.K. indefinitely banned new puberty blocker prescriptions for transgender minors due to insufficient evidence of benefits and safety concerns, following an independent review; existing users can continue treatment, and the ban will be revisited in 2027.
U.K. Indefinitely Bans New Puberty Blocker Prescriptions for Transgender Minors
The U.K. indefinitely banned new puberty blocker prescriptions for transgender minors due to insufficient evidence of benefits and safety concerns, following an independent review; existing users can continue treatment, and the ban will be revisited in 2027.
Progress
60% Bias Score
UK Bans Puberty Blockers for Gender Dysphoria
The British government indefinitely banned puberty blockers for children with gender dysphoria due to safety concerns, reversing previous practices and contradicting international medical standards; a clinical trial is planned for 2024.
UK Bans Puberty Blockers for Gender Dysphoria
The British government indefinitely banned puberty blockers for children with gender dysphoria due to safety concerns, reversing previous practices and contradicting international medical standards; a clinical trial is planned for 2024.
Progress
56% Bias Score
Puberty Blockers for Gender Dysphoria: Clinical Trial Proposed Amidst Controversy
Due to insufficient evidence, routine use of puberty blockers for gender dysphoria in children was halted; a clinical trial is proposed to assess potential benefits and harms, addressing polarized views and a lack of robust data.
Puberty Blockers for Gender Dysphoria: Clinical Trial Proposed Amidst Controversy
Due to insufficient evidence, routine use of puberty blockers for gender dysphoria in children was halted; a clinical trial is proposed to assess potential benefits and harms, addressing polarized views and a lack of robust data.
Progress
60% Bias Score
Wales Puberty Blocker Ban Challenged for Unlawful Process
The Welsh government's ban on puberty blockers for under-18s questioning their gender identity is unlawful, according to a Plaid Cymru politician, due to the lack of a required impact assessment, raising concerns about children's rights.
Wales Puberty Blocker Ban Challenged for Unlawful Process
The Welsh government's ban on puberty blockers for under-18s questioning their gender identity is unlawful, according to a Plaid Cymru politician, due to the lack of a required impact assessment, raising concerns about children's rights.
Progress
44% Bias Score
UK Bans Puberty Blockers for Minors Amidst Growing European Concerns
The United Kingdom has banned puberty blockers for children under 18, joining other Western European nations restricting access amid concerns about long-term effects and insufficient evidence of efficacy; this follows a temporary ban and challenges the previously accepted "Dutch protocol."
UK Bans Puberty Blockers for Minors Amidst Growing European Concerns
The United Kingdom has banned puberty blockers for children under 18, joining other Western European nations restricting access amid concerns about long-term effects and insufficient evidence of efficacy; this follows a temporary ban and challenges the previously accepted "Dutch protocol."
Progress
52% Bias Score
UK Indefinitely Bans Puberty Blockers for Children
The UK government has indefinitely banned puberty blockers for children due to safety concerns raised by the Commission on Human Medicines, following an independent review that found insufficient evidence to support their use and concerns about informed consent. The ban will be reviewed in 2027.
UK Indefinitely Bans Puberty Blockers for Children
The UK government has indefinitely banned puberty blockers for children due to safety concerns raised by the Commission on Human Medicines, following an independent review that found insufficient evidence to support their use and concerns about informed consent. The ban will be reviewed in 2027.
Progress
64% Bias Score
UK Indefinitely Bans Puberty Blockers for Under-18s
The UK government has indefinitely banned puberty blockers for under-18s with gender dysphoria due to safety concerns raised by the Commission on Human Medicines and the Cass Review, impacting access to these treatments across the UK and prompting a future clinical trial.
UK Indefinitely Bans Puberty Blockers for Under-18s
The UK government has indefinitely banned puberty blockers for under-18s with gender dysphoria due to safety concerns raised by the Commission on Human Medicines and the Cass Review, impacting access to these treatments across the UK and prompting a future clinical trial.
Progress
60% Bias Score
Showing 1 to 10 of 10 results